Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.


Drug Delivery

On-demand pain relief, triggered by light

Injectable material can be repeatedly stimulated with near-infrared light to release painkillers

by Prachi Patel
January 19, 2017

Credit: Nano Lett.
Gold nanorods (green) on the surface of a liposome heat up when exposed to near-infrared light. The heat frees molecules of the lipid1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine (yellow) in the particle’s membrane, releasing a burst of the pain blocking drug tetrodotoxin (purple).

Once injected into the body, a new material can repeatedly release small bursts of local anesthetic when zapped by low-intensity, near-infrared light for one minute (Nano Lett. 2016, DOI: 10.1021/acs.nanolett.6b03588). The material’s developers, who have tested it in rats, say the on-demand system could make pain management safer and more effective, and give patients more control.

Credit: Nano Lett.
Gold nanorods (black) attached to the surface of spherical liposomes absorb near-infrared light and convert it into heat, which opens up pores on the liposome’s surface, allowing it to eject some of its payload of painkillers.
Credit: Nano Lett.
Gold nanorods (black) attached to the surface of spherical liposomes absorb near-infrared light and convert it into heat, which opens up pores on the liposome’s surface, allowing it to eject some of its payload of painkillers.

People suffering from chronic or post-surgical pain are typically prescribed narcotics or given anesthetic shots to dull pain. But both have drawbacks: Narcotics can be addictive, while anesthetics don’t last long and injecting the right dosage at the site of pain can be a challenge.

To improve control over anesthetic delivery, scientists have encapsulated drugs in liposomes, hollow sacs made of phospholipids, which are leaky enough to release a drug slowly over a period of time. “The problem is, there’s no way to turn it on and off,” says Daniel S. Kohane of Harvard Medical School.

So in 2015, Kohane and his colleagues made liposomes that can be controlled from outside the body with tissue-penetrating near-infrared light. The researchers decorated the liposome surface with gold nanorods, which absorb near-IR and generate heat. The heat expands the phospholipid membrane, making it more permeable so that some of the particle’s payload escapes quickly. The liposomes needed 10 minutes of light exposure to release their payload (Nano Lett. 2015, DOI: 10.1021/acs.nanolett.5b03440). But high intensity or long irradiation time can cause tissue burns, Kohane says.

To make particles that are triggered in just a minute or two with lower intensity light, the researchers add a new lipid to the membrane: 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine (MSPC), which can break free of the membrane when heated by the gold nanorods. The researchers speculate that this process opens up pores that allow a greater portion of the payload to be ejected than from a membrane without MSPC.

In benchtop experiments, when they loaded the little lipid sacs with the nerve blocker tetrodotoxin and shined near-IR on them for a minute or two, the drug flowed out of the particles. The release stopped after a few hours once the particle wall cooled and tightened up again, but could be repeated with additional light bursts that cause more MSPC molecules to break free of the membrane. This could provide the basis for an on-demand drug delivery system to address pain, Kohane says.

The researchers tested the system by injecting the liposomes into the footpads of rats. They shined near-IR light at a high enough intensity to penetrate the skin but below what would cause tissue damage on the footpad for a minute. Then they poked the footpads every half hour. Treated animals indicated no pain for the first two hours, after which the effect began wearing off. Full pain response returned after six hours. The researchers also used the material to repeatedly block one leg’s sciatic nerve so that test animals lost sensation in that leg.

“This is an impressive application for light-induced drug delivery,” says Jonathan F. Lovell, a biomedical engineer at the University at Buffalo, SUNY. Although the technique would be limited to nerves located no more than a few centimeters under the skin, it would allow doctors to fine-tune the doses for nerve blocking, he adds. “The current standard of direct injection can have highly variable results, which you know if you’ve ever had a gum numbed at the dentist’s.”



This article has been sent to the following recipient:

Dianne (January 20, 2017 9:46 PM)
Is this available now, how do I try it? I have had 3 back surgeries and I am in constant pain even when I am on strong meds. Is there a trial going on? I would be willing to be a tester.
Thank you, Dianne
Robin Murray (January 21, 2017 2:07 AM)
Have many dxs:sciatica, failed back syndrome, stenosis,fusions,osteoporosis,adult progressive scoliosis,2016 hip replacement,spinal stimulator implant & tired of drawbacks long-term opiod/topical/ice/Cymbalta/PT/injections/etc. Am compliant retired disabled PICUnurse-great candidate for such a trial. Still drive, ambulate without a cane,pls consider me for such a program.
Mary Bush (January 21, 2017 9:42 AM)
I have suffered from chronic back pain for two years now and the ONLY thing tha works I medication. Injections of any kind have had no effect at all. I am curious to know what the side effects are from thiis new product. Thank you. Mary.

Terri (January 25, 2017 3:52 PM)
I read this column with interest and wonder if this pain management strategy might help my 85 year old father. He has severe spinal stenosis, and, after numerous procedures that failed to control the pain, had a spinal stimulator implant. He still suffers from severe pain as well as suffering many of the drawbacks from long-term opioid use. Please contact me if you think he might be a candidate for any planned trial. Many thanks, Terri

Leave A Comment

*Required to comment